WHO Updates Dementia Prevention Guidelines: 45% of Risk is Modifiable

Dementia Prevention: New WHO Evidence-Based Recommendations

The World Health Organization has released updated guidelines on reducing cognitive decline and dementia risk across the lifespan. With over 57 million people currently living with dementia worldwide and nearly 10 million new diagnoses annually, these recommendations provide actionable public health guidance for prevention strategies.

Key Modifiable Risk Factors

The guidelines identify that approximately 45% of dementia risk stems from modifiable factors:

  • Behavioral factors: Tobacco use, excessive alcohol consumption, physical inactivity, and social isolation
  • Environmental exposure: Air pollution
  • Medical conditions: Uncontrolled hypertension, diabetes, and elevated cholesterol

Recommended Interventions

Evidence-based strategies to reduce dementia risk include:

  • Cognitive training and mental stimulation for cognitively normal individuals and those with mild cognitive impairment
  • Regular social engagement and activities
  • Increased physical activity
  • Adoption of heart-healthy dietary patterns
  • Tobacco cessation
  • Moderation of alcohol consumption
  • Management of cardiometabolic conditions
  • Consideration of hearing aids for hearing loss
  • Reduction of air pollution exposure

What the Evidence Does NOT Support

The guidelines explicitly note insufficient evidence for dementia prevention through:

  • Vitamin B supplementation
  • Vitamin E supplementation
  • Omega-3 polyunsaturated fatty acids (PUFA) supplements
  • Multivitamin/mineral supplementation

These are not recommended as preventive interventions absent documented nutritional deficiencies.

Global Health Impact

Dementia carries substantial economic burden—estimated at $1.3 trillion annually—with approximately half representing unpaid family and caregiver costs. Beyond economics, dementia significantly impacts independence, dignity, and safety.

Pharmacist's Note: As medication experts, pharmacists play an important counseling role in dementia prevention. We can reinforce medication adherence for hypertension and diabetes management, counsel on appropriate supplement use (discouraging unnecessary B, E, and omega-3 supplementation for healthy individuals), and identify potential drug-disease interactions. We should also screen for polypharmacy and deprescribe medications when appropriate, as excessive medication burden itself can contribute to cognitive concerns in older adults. Additionally, pharmacists can advocate for patients regarding hearing aid access and support lifestyle modifications through patient education.

For Travelers and Expatriates

International travelers should recognize that dementia prevention is a long-term health endeavor. When traveling or relocating internationally, maintaining preventive practices—regular physical activity, cognitive engagement, social connections, and management of chronic diseases—remains important regardless of destination. Travelers should ensure continuity of care for hypertension and diabetes management and maintain medication adherence throughout their journey.

Primary sources

PharmTrip may include promotional content. Products and services are independently evaluated by a licensed pharmacist and rankings are never altered by advertiser requests. Information reflects what was current at the time of writing — please verify the latest terms on each provider's official site.